B. Mellado González

615 total citations
14 papers, 349 citations indexed

About

B. Mellado González is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, B. Mellado González has authored 14 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in B. Mellado González's work include Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). B. Mellado González is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). B. Mellado González collaborates with scholars based in Spain, United States and United Kingdom. B. Mellado González's co-authors include Sebastián Luna-Moré, C. Sánchez Acedo, Isabel Rodrigo, Julio Vázquez, Pablo Maroto, Begoña P. Valderrama, Gwénaëlle Gravis, Ekaterini Boleti, Aranzazu González del Alba and Alejo Rodríguez‐Vida and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Pharmacogenomics.

In The Last Decade

B. Mellado González

13 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Mellado González Spain 6 200 164 139 112 89 14 349
C. Sánchez Acedo Spain 2 197 1.0× 154 0.9× 139 1.0× 88 0.8× 61 0.7× 4 323
Sebastián Luna-Moré Spain 7 330 1.6× 286 1.7× 235 1.7× 143 1.3× 93 1.0× 8 511
Lina Patel‐Parekh United States 6 275 1.4× 280 1.7× 164 1.2× 142 1.3× 131 1.5× 8 471
Carey A. Eberle United States 7 161 0.8× 206 1.3× 101 0.7× 233 2.1× 55 0.6× 10 425
Ulrika A. Hänninen Finland 7 129 0.6× 73 0.4× 27 0.2× 159 1.4× 48 0.5× 10 330
Marvin Pietruszka United States 6 309 1.5× 164 1.0× 258 1.9× 68 0.6× 98 1.1× 11 388
Ronald Tickman United States 10 204 1.0× 185 1.1× 112 0.8× 63 0.6× 105 1.2× 17 380
Punam Bhanot United States 7 346 1.7× 50 0.3× 41 0.3× 391 3.5× 122 1.4× 8 546
Ernesto Gil Deza Argentina 6 106 0.5× 81 0.5× 49 0.4× 159 1.4× 62 0.7× 27 317
Vesna Vrcel United States 7 192 1.0× 228 1.4× 28 0.2× 92 0.8× 133 1.5× 9 293

Countries citing papers authored by B. Mellado González

Since Specialization
Citations

This map shows the geographic impact of B. Mellado González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mellado González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mellado González more than expected).

Fields of papers citing papers by B. Mellado González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Mellado González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mellado González. The network helps show where B. Mellado González may publish in the future.

Co-authorship network of co-authors of B. Mellado González

This figure shows the co-authorship network connecting the top 25 collaborators of B. Mellado González. A scholar is included among the top collaborators of B. Mellado González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Mellado González. B. Mellado González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bergmann, Lars, Marit Ahrens, M. Gross Goupil, et al.. (2024). LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial. Annals of Oncology. 35. S1263–S1263. 14 indexed citations
2.
3.
González, B. Mellado, Miguel Á. Climent Durán, Xavier García del Muro, et al.. (2023). 2366P Phase I-II study of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial). Annals of Oncology. 34. S1204–S1204.
4.
Rodríguez, A., Caterina Aversa, Leonardo Rodríguez‐Carunchio, et al.. (2023). 2398P Are fibroblast growth factor receptor 3 (FGFR3) alterations a possible predictive factor for platinum-based chemotherapy and immunotherapy in metastatic urothelial carcinoma (MUC)?. Annals of Oncology. 34. S1220–S1221. 1 indexed citations
5.
6.
Garrigós, Carmen, Javier Puente, B. Mellado González, et al.. (2022). Single-Nucleotide Polymorphism Associations with Efficacy and Toxicity in Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel. Pharmacogenomics. 23(11). 627–638. 1 indexed citations
7.
Carles, Joan, Teresa Alonso, B. Mellado González, et al.. (2020). 639P 223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide. Annals of Oncology. 31. S525–S526. 1 indexed citations
8.
9.
10.
Rivas‐Delgado, Alfredo, Laura Magnano, Pablo Mozas, et al.. (2017). Progression‐free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era. Hematological Oncology. 35(S2). 360–361. 4 indexed citations
11.
Chi, K.N., Daniel Castellano, Johann S. de Bono, et al.. (2015). 2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC). European Journal of Cancer. 51. S493–S493. 1 indexed citations
12.
Valderrama, Begoña P., Albert Font Pous, Juan Antonio Virizuela Echaburu, et al.. (2015). 2635 MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39. European Journal of Cancer. 51. S524–S525. 1 indexed citations
13.
Vázquez, Julio, et al.. (2012). Gastrointestinal Stromal Tumor Arising in the Rectovaginal Septum. Journal of Lower Genital Tract Disease. 16(2). 158–161. 16 indexed citations
14.
Luna-Moré, Sebastián, et al.. (1994). Invasive micropapillary carcinoma of the breast. Pathology - Research and Practice. 190(7). 668–674. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Sánchez Acedo Breakdown of academic impact, for papers by Sebastián Luna-Moré Breakdown of academic impact, for papers by Lina Patel‐Parekh Breakdown of academic impact, for papers by Carey A. Eberle Breakdown of academic impact, for papers by Ulrika A. Hänninen Breakdown of academic impact, for papers by Marvin Pietruszka Breakdown of academic impact, for papers by Ronald Tickman Breakdown of academic impact, for papers by Punam Bhanot Breakdown of academic impact, for papers by Ernesto Gil Deza Breakdown of academic impact, for papers by Vesna Vrcel
Rankless by CCL
2026